- Home
- CCLDO vs RVPHW Comparison
CCLDO vs RVPHW Comparison
Compare CCLDO & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLDO
- RVPHW
- Stock Information
- Founded
- CCLDO N/A
- RVPHW 2018
- Country
- CCLDO United States
- RVPHW United States
- Employees
- CCLDO 3650
- RVPHW 14
- Industry
- CCLDO Computer Software: Prepackaged Software
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- CCLDO Technology
- RVPHW Health Care
- Exchange
- CCLDO Nasdaq
- RVPHW Nasdaq
- Market Cap
- CCLDO N/A
- RVPHW N/A
- IPO Year
- CCLDO N/A
- RVPHW N/A
- Fundamental
- Price
- CCLDO $21.72
- RVPHW $0.05
- Analyst Decision
- CCLDO
- RVPHW
- Analyst Count
- CCLDO 0
- RVPHW 0
- Target Price
- CCLDO N/A
- RVPHW N/A
- AVG Volume (30 Days)
- CCLDO N/A
- RVPHW 22.4K
- Earning Date
- CCLDO N/A
- RVPHW 03-14-2025
- Dividend Yield
- CCLDO N/A
- RVPHW N/A
- EPS Growth
- CCLDO N/A
- RVPHW N/A
- EPS
- CCLDO N/A
- RVPHW N/A
- Revenue
- CCLDO N/A
- RVPHW N/A
- Revenue This Year
- CCLDO N/A
- RVPHW N/A
- Revenue Next Year
- CCLDO N/A
- RVPHW N/A
- P/E Ratio
- CCLDO N/A
- RVPHW N/A
- Revenue Growth
- CCLDO N/A
- RVPHW N/A
- 52 Week Low
- CCLDO N/A
- RVPHW $0.13
- 52 Week High
- CCLDO N/A
- RVPHW $0.15
- Technical
- Relative Strength Index (RSI)
- CCLDO 53.45
- RVPHW 48.13
- Support Level
- CCLDO $21.27
- RVPHW $0.04
- Resistance Level
- CCLDO $21.78
- RVPHW $0.09
- Average True Range (ATR)
- CCLDO 0.34
- RVPHW 0.01
- MACD
- CCLDO -0.02
- RVPHW 0.00
- Stochastic Oscillator
- CCLDO 71.06
- RVPHW 33.86
About CCLDO CareCloud Inc.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.